High-flow nasal oxygen versus noninvasive ventilation for hypoxemic respiratory failure: Do we know enough?

Ann Thorac Med · 2016 · PMC4966217 · PMID 27512504

Europe PMC DOI

hedged sentence

0.1800

closest p · 3.6× alpha

0.1800

boldest claim

The sentences

did not reach statistical significanceP = 0.18not close (p > 0.1)

Although the primary outcome variable, intubation rate, did not reach statistical significance, there was a trend toward a favorable effect of HFNO over the other 2 therapies (38%, 47%, and 50% for HFNO, SO, and NIV, respectively, P = 0.18).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.